SLQT RSI Chart
Last 7 days
-6.4%
Last 30 days
-16.2%
Last 90 days
36.4%
Trailing 12 Months
47.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 920.5M | 1.0B | 1.1B | 1.2B |
2022 | 808.3M | 764.0M | 770.5M | 895.4M |
2021 | 888.5M | 930.7M | 962.6M | 799.3M |
2020 | 464.5M | 531.5M | 590.5M | 771.8M |
2019 | 311.5M | 337.5M | 346.7M | 403.1M |
2018 | 0 | 233.7M | 259.6M | 285.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2024 | clement ryan moore | acquired | - | - | 6,234 | chief financial officer |
Feb 28, 2024 | clement ryan moore | acquired | - | - | 20,833 | chief financial officer |
Nov 14, 2023 | devanny earl h iii | acquired | - | - | 203,125 | - |
Nov 14, 2023 | devine denise l | acquired | - | - | 203,125 | - |
Nov 14, 2023 | patel kavita | acquired | - | - | 203,125 | - |
Nov 14, 2023 | weldon raymond f | acquired | - | - | 203,125 | - |
Nov 14, 2023 | hawks donald l iii | acquired | - | - | 203,125 | - |
Nov 14, 2023 | grant w thomas ii | acquired | - | - | 203,125 | - |
Sep 18, 2023 | matthews joshua brandon | bought | 113,295 | 1.162 | 97,500 | president, selectquote senior |
Sep 15, 2023 | grant w thomas ii | bought | 256,637 | 1.166 | 220,100 | - |
Which funds bought or sold SLQT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Bank of New York Mellon Corp | reduced | -8.55 | 207,989 | 828,736 | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | sold off | -100 | -5,000 | - | -% |
Apr 24, 2024 | COUNTRY CLUB BANK /GFN | unchanged | - | 10,985 | 39,230 | -% |
Apr 24, 2024 | Cambridge Investment Research Advisors, Inc. | reduced | -4.63 | 6,000 | 21,000 | -% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -63.17 | -8,000 | 9,000 | -% |
Apr 23, 2024 | TriaGen Wealth Management LLC | added | 24.69 | 45,515 | 101,000 | 0.04% |
Apr 23, 2024 | Canvas Wealth Advisors, LLC | unchanged | - | 8,740 | 31,730 | 0.01% |
Apr 22, 2024 | RAYMOND JAMES & ASSOCIATES | unchanged | - | 16,380 | 52,000 | -% |
Apr 22, 2024 | MetLife Investment Management, LLC | unchanged | - | 14,548 | 99,651 | -% |
Apr 19, 2024 | BOURGEON CAPITAL MANAGEMENT LLC | sold off | -100 | -8,220 | - | -% |
Unveiling Selectquote Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Selectquote Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ARGO | 1.0T | 1.3B | -4.8K | 757.88 | ||||
AJG | 50.7B | 10.1B | 52.29 | 5.04 | ||||
AIG | 50.7B | 46.8B | 13.92 | 1.08 | ||||
TRV | 48.9B | 42.9B | 15.57 | 1.14 | ||||
AFL | 48.2B | 18.7B | 10.35 | 2.58 | ||||
ACGL | 34.0B | 13.6B | 7.65 | 2.49 | ||||
AFG | 10.6B | 7.8B | 12.5 | 1.36 | ||||
MID-CAP | ||||||||
UNM | 9.7B | 12.4B | 7.57 | 0.78 | ||||
AIZ | 9.0B | 11.1B | 13.97 | 0.81 | ||||
LNC | 4.7B | 11.6B | -6.27 | 0.41 | ||||
AEL | 4.5B | 2.8B | 21.25 | 1.58 | ||||
SMALL-CAP | ||||||||
BRP | 1.6B | 1.2B | -17.8 | 1.32 | ||||
AMSF | 872.2M | 308.9M | 14.14 | 2.82 | ||||
AMBC | 659.9M | 269.0M | 146.63 | 2.45 | ||||
AAME | 40.0M | 186.8M | -233.85 | 0.21 |
Selectquote Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 74.2% | 405,438,000 | 232,730,000 | 221,778,000 | 299,398,000 | 319,188,000 | 162,484,000 | 139,390,000 | 274,339,000 | 194,237,000 | 156,079,000 | 183,598,500 | 265,346,000 | 357,565,000 | 124,169,000 | 141,447,000 | 148,604,000 | 176,297,000 | 65,167,000 | 74,399,000 | 87,211,000 | 119,938,000 |
Cost Of Revenue | 34.4% | 97,424,000 | 72,511,000 | 65,697,000 | 79,186,000 | 91,477,000 | 65,164,000 | 72,058,000 | 96,491,000 | 136,189,000 | 86,791,000 | - | - | - | - | - | - | - | - | - | - | - |
Costs and Expenses | 37.2% | 350,144,000 | 255,145,000 | 257,439,000 | 265,671,000 | 266,155,000 | 202,000,000 | 258,072,000 | 272,008,000 | 367,887,000 | 212,087,000 | 174,488,000 | 212,240,000 | 234,120,000 | 116,895,000 | 105,585,000 | 108,162,000 | 118,862,000 | 66,577,000 | - | - | - |
S&GA Expenses | 16.6% | 33,412,000 | 28,666,000 | 49,856,000 | 27,544,000 | 28,412,000 | 30,706,000 | 30,450,500 | 24,705,000 | 21,894,000 | 23,895,000 | 18,618,000 | 19,251,000 | 13,043,000 | 12,202,000 | 9,504,000 | 6,656,000 | 13,997,000 | 5,126,000 | - | - | - |
EBITDA Margin | -5.7% | 0.05 | 0.05 | 0.04 | -0.05 | -0.08 | -0.39 | -0.42 | -0.24 | -0.19 | 0.15 | 0.22 | 0.25 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 14.1% | 24,415,000 | 21,397,000 | 21,721,000 | 21,105,000 | 21,044,000 | 16,736,000 | 12,294,500 | 12,179,000 | 10,587,000 | 8,535,000 | 8,422,000 | 7,355,000 | 6,782,000 | 6,761,000 | 8,356,000 | 9,356,000 | 6,178,000 | 705,000 | - | - | - |
Income Taxes | 189.7% | 11,487,000 | -12,799,000 | -9,547,000 | 3,152,000 | 9,405,000 | -13,610,000 | -26,318,000 | -2,846,000 | -46,725,000 | -16,413,000 | 1,163,500 | 6,852,000 | 26,391,000 | -1,104,000 | 5,392,000 | 7,366,000 | 12,184,000 | -440,000 | - | - | - |
Earnings Before Taxes | 170.4% | 30,879,000 | -43,850,000 | -57,385,000 | 12,416,000 | 31,919,000 | -56,094,000 | -131,002,000 | -9,871,000 | -184,288,000 | -64,645,000 | 645,500 | 42,087,000 | 116,247,000 | -267,000 | 23,778,000 | 31,082,000 | 51,254,000 | -2,128,000 | - | - | - |
EBT Margin | 5.7% | -0.05 | -0.05 | -0.07 | -0.16 | -0.18 | -0.49 | -0.51 | -0.32 | -0.26 | 0.10 | 0.17 | 0.20 | - | - | - | - | - | - | - | - | - |
Net Income | 162.5% | 19,392,000 | -31,051,000 | -47,838,000 | 9,264,000 | 22,514,000 | -42,484,000 | -104,684,000 | -7,025,000 | -137,563,000 | -48,232,000 | -518,000 | 35,235,000 | 89,856,000 | 837,000 | 20,049,000 | 23,716,000 | 39,070,000 | -1,688,000 | 12,886,000 | 22,238,000 | 34,663,000 |
Net Income Margin | 1.3% | -0.04 | -0.04 | -0.06 | -0.13 | -0.15 | -0.38 | -0.39 | -0.24 | -0.19 | 0.08 | 0.13 | 0.16 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -11.2% | -27,014,000 | -24,287,000 | -6,933,000 | 62,281,000 | -28,704,000 | -47,468,000 | -54,235,000 | 14,768,000 | -228,746,000 | -94,899,000 | -62,882,000 | 41,449,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q2 |
Assets | 5.6% | 1,236 | 1,170 | 1,219 | 1,288 | 1,298 | 1,249 | 1,290 | 1,435 | 1,445 | 1,390 | 1,424 | 1,434 | 1,262 | 1,114 | 1,074 | 407 |
Current Assets | 13.7% | 388 | 341 | 363 | 384 | 404 | 378 | 403 | 458 | 556 | 444 | 483 | 591 | 477 | 480 | 514 | 103 |
Cash Equivalents | -77.6% | 11.00 | 48.00 | 83.00 | 92.00 | 36.00 | 71.00 | 141 | 199 | 193 | 184 | 286 | 369 | 210 | 305 | 369 | 1.00 |
Inventory | - | - | - | 6.00 | - | - | - | 6.00 | - | - | - | 0.00 | - | - | - | - | - |
Goodwill | 0% | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 74.00 | 74.00 | 74.00 | 68.00 | 50.00 | 46.00 | 46.00 | 47.00 | 5.00 |
Liabilities | 5.4% | 899 | 853 | 872 | 897 | 916 | 893 | 899 | 939 | 952 | 756 | 757 | 764 | 628 | 569 | 528 | 144 |
Current Liabilities | 34.5% | 184 | 137 | 137 | 147 | 164 | 145 | 114 | 124 | 135 | 128 | 109 | 115 | 141 | 108 | 96.00 | 33.00 |
Long Term Debt | -1.6% | 651 | 661 | 665 | 667 | 670 | 673 | 698 | 699 | 700 | 459 | 459 | 461 | 313 | 313 | 312 | 11.00 |
LT Debt, Current | 26.2% | 43.00 | 34.00 | 34.00 | 25.00 | 21.00 | 17.00 | 7.00 | 7.00 | 7.00 | 4.00 | 2.00 | - | - | - | - | - |
LT Debt, Non Current | -1.6% | 651 | 661 | 665 | 667 | 670 | 673 | 698 | 699 | 700 | 459 | 459 | 461 | 313 | 313 | 312 | 11.00 |
Shareholder's Equity | 6.2% | 337 | 317 | 347 | 391 | 382 | 357 | 391 | 493 | 489 | 623 | 667 | 666 | 631 | 542 | 544 | 262 |
Retained Earnings | 7.3% | -247 | -266 | -235 | -187 | -197 | -219 | -177 | -68.68 | -62.24 | 83.00 | 120 | 125 | 88.00 | -1.95 | -2.79 | 200 |
Additional Paid-In Capital | 0.7% | 574 | 570 | 567 | 564 | 561 | 559 | 555 | 554 | 551 | 549 | 545 | 544 | 545 | 547 | 548 | 138 |
Shares Outstanding | 0.5% | 168 | 167 | 167 | 167 | 166 | 165 | 164 | 164 | 164 | 164 | 163 | 163 | - | - | - | - |
Float | - | - | - | - | - | 91.00 | - | - | - | 1,214 | - | - | - | 2,576 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q2 |
Cashflow From Operations | -8.0% | -25,568 | -23,671 | -6,542 | 62,739 | -28,404 | -47,170 | -53,952 | 21,379 | -218,666 | -87,075 | -54,495 | 42,201 | -93,802 | -9,346 | -19,744 | 8,570 | -38,905 | -11,697 | - | - |
Share Based Compensation | 20.4% | 3,822 | 3,175 | 2,785 | 2,959 | 2,936 | 2,630 | 800 | 2,143 | 1,894 | 2,215 | 1,476 | 1,430 | 1,335 | 924 | 215 | 20.00 | - | - | - | - |
Cashflow From Investing | -65.4% | -3,547 | -2,145 | -2,265 | -2,392 | -2,083 | -2,385 | -2,564 | -8,950 | -13,295 | -17,767 | -27,810 | -27,110 | -4,881 | -4,215 | -40,745 | -2,695 | -3,649 | -4,281 | - | - |
Cashflow From Financing | 3.7% | -8,522 | -8,854 | -85.00 | -4,396 | -4,499 | -20,359 | -1,846 | -6,427 | 241,700 | 2,006 | -289 | 108,050 | -2,781 | -7,938 | 345,732 | -117 | 119,569 | 16,262 | - | - |
Dividend Payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Revenues [Abstract] | ||||
Total revenue | $ 405,438 | $ 319,188 | $ 638,167 | $ 481,672 |
OPERATING COSTS AND EXPENSES: | ||||
Cost of revenue | 97,424 | 91,477 | 169,935 | 156,641 |
Cost of goods sold—pharmacy revenue | 94,180 | 50,096 | 178,188 | 92,450 |
Marketing and advertising | 117,078 | 89,925 | 179,400 | 147,519 |
Selling, general, and administrative | 33,412 | 28,412 | 62,078 | 59,118 |
Technical development | 8,050 | 6,245 | 15,687 | 12,427 |
Total operating costs and expenses | 350,144 | 266,155 | 605,288 | 468,155 |
INCOME FROM OPERATIONS | 55,294 | 53,033 | 32,879 | 13,517 |
INTEREST EXPENSE, NET | (24,415) | (21,044) | (45,811) | (37,780) |
OTHER INCOME (EXPENSE), NET | 0 | (70) | (39) | 88 |
INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT) | 30,879 | 31,919 | (12,971) | (24,175) |
INCOME TAX EXPENSE (BENEFIT) | 11,487 | 9,405 | (1,312) | (4,205) |
NET INCOME (LOSS) | $ 19,392 | $ 22,514 | $ (11,659) | $ (19,970) |
NET INCOME (LOSS) PER SHARE: | ||||
Basic (in dollars per share) | $ 0.12 | $ 0.14 | $ (0.07) | $ (0.12) |
Diluted (in dollars per share) | $ 0.11 | $ 0.14 | $ (0.07) | $ (0.12) |
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS: | ||||
Basic (in shares) | 168,349 | 166,486 | 167,901 | 165,655 |
Diluted (in shares) | 169,737 | 166,548 | 167,901 | 165,655 |
OTHER COMPREHENSIVE INCOME (LOSS) NET OF TAX: | ||||
Gain (loss) on cash flow hedge | $ (3,422) | $ (381) | $ (5,432) | $ 4,019 |
OTHER COMPREHENSIVE INCOME (LOSS) | (3,422) | (381) | (5,432) | 4,019 |
COMPREHENSIVE INCOME (LOSS) | 15,970 | 22,133 | (17,091) | (15,951) |
Commission | ||||
Revenues [Abstract] | ||||
Total revenue | 263,225 | 230,033 | 380,981 | 336,368 |
Pharmacy | ||||
Revenues [Abstract] | ||||
Total revenue | 108,795 | 51,601 | 203,583 | 92,694 |
Other | ||||
Revenues [Abstract] | ||||
Total revenue | $ 33,418 | $ 37,554 | $ 53,603 | $ 52,610 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 10,849 | $ 83,156 |
Accounts receivable, net of allowances of $4.7 million and $2.7 million, respectively | 142,590 | 154,565 |
Commissions receivable-current | 207,279 | 111,148 |
Other current assets | 27,100 | 14,355 |
Total current assets | 387,818 | 363,224 |
COMMISSIONS RECEIVABLE—Net | 747,079 | 729,350 |
PROPERTY AND EQUIPMENT—Net | 23,389 | 27,452 |
SOFTWARE—Net | 14,428 | 14,740 |
OPERATING LEASE RIGHT-OF-USE ASSETS | 22,035 | 23,563 |
INTANGIBLE ASSETS—Net | 8,684 | 10,200 |
GOODWILL | 29,136 | 29,136 |
OTHER ASSETS | 3,350 | 21,586 |
TOTAL ASSETS | 1,235,919 | 1,219,251 |
CURRENT LIABILITIES: | ||
Accounts payable | 57,392 | 27,577 |
Accrued expenses | 16,698 | 16,993 |
Accrued compensation and benefits | 48,680 | 49,966 |
Operating lease liabilities—current | 5,133 | 5,175 |
Current portion of long-term debt | 42,766 | 33,883 |
Contract liabilities | 9,092 | 1,691 |
Other current liabilities | 4,211 | 1,972 |
Total current liabilities | 183,972 | 137,257 |
LONG-TERM DEBT, NET—less current portion | 650,772 | 664,625 |
DEFERRED INCOME TAXES | 36,668 | 39,581 |
OPERATING LEASE LIABILITIES | 25,245 | 27,892 |
OTHER LIABILITIES | 2,745 | 2,926 |
Total liabilities | 899,402 | 872,281 |
COMMITMENTS AND CONTINGENCIES | ||
SHAREHOLDERS’ EQUITY: | ||
Common stock, $0.01 par value | 1,690 | 1,669 |
Additional paid-in capital | 573,883 | 567,266 |
Accumulated deficit | (247,303) | (235,644) |
Accumulated other comprehensive income | 8,247 | 13,679 |
Total shareholders’ equity | 336,517 | 346,970 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 1,235,919 | $ 1,219,251 |